We have found that tamoxifen-resistant cells are enriched for CSCs and express high levels of the stem cell marker Sox2 [29], which is also expressed in normal breast stem cells, although at lower levels than in breast tumor cells [30,31]. The gene discussed is SOX2; the disease is breast neoplasm.